{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:47:06Z","timestamp":1768686426936,"version":"3.49.0"},"reference-count":51,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The invasion of microbial pathogens and\/or sterile inflammation caused by physical\/chemical injuries, increased ocular pressure, oxidative stress, and ischemia could lead to the generation of detrimental immune responses in the eyes, which result in excessive tissue injury and vision loss. The bioavailability of eye drops that are enriched with immunoregulatory and trophic factors which may concurrently suppress intraocular inflammation and promote tissue repair and regeneration is generally low. We recently developed \u201cderived- Multiple Allogeneic Proteins Paracrine Signaling regenerative biologics platform technology d-MAPPS\u2122\u201d, a bioengineered biological product which is enriched with immunomodulatory and trophic factors that can efficiently suppress detrimental immune responses in the eye and promote the repair and regeneration of injured corneal and retinal tissues. The results obtained in preclinical and clinical studies showed that d-MAPPS\u2122 increased the viability of injured corneal cells, inhibited the production of inflammatory cytokines in immune cells, alleviated inflammation, and restored vision loss in patients suffering from meibomian gland dysfunction and dry eye disease. Herewith, we emphasized molecular mechanisms responsible for the therapeutic efficacy of d-MAPPS\u2122 and we presented the main beneficial effects of d-MAPPS\u2122 in clinical settings, indicating that the topical administration of d-MAPPS\u2122 could be considered a new therapeutic approach for the treatment of ocular inflammatory diseases and for the repair and regeneration of injured corneal and retinal tissues.<\/jats:p>","DOI":"10.3390\/ijms232113528","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T09:15:37Z","timestamp":1667553337000},"page":"13528","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic Potential of d-MAPPS\u2122 for Ocular Inflammatory Diseases and Regeneration of Injured Corneal and Retinal Tissue"],"prefix":"10.3390","volume":"23","author":[{"given":"Carl Randall","family":"Harrell","sequence":"first","affiliation":[{"name":"Regenerative Processing Plant, LLC, 34176 US Highway 19 N Palm Harbor, Palm Harbor, FL 34684, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3410\/B2-3","article-title":"Ocular immune privilege","volume":"2","author":"Zhou","year":"2010","journal-title":"F1000 Biol. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1189\/jlb.3RI0615-239R","article-title":"Parainflammation, chronic inflammation, and age-related macular degeneration","volume":"98","author":"Chen","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.it.2015.04.003","article-title":"Immune mechanisms in inflammatory and degenerative eye disease","volume":"36","author":"Perez","year":"2015","journal-title":"Trends Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"847937","DOI":"10.3389\/fimmu.2022.847937","article-title":"Contribution of Interleukin-17A to Retinal Degenerative Diseases","volume":"13","author":"Zhong","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"109007","DOI":"10.1016\/j.exer.2022.109007","article-title":"Immune regulation of the ocular surface","volume":"218","author":"Chen","year":"2022","journal-title":"Exp. Eye Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Dammak, A., Huete-Toral, F., Carpena-Torres, C., Martin-Gil, A., Pastrana, C., and Carracedo, G. (2021). From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13091376"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kaur, G., and Singh, N.K. (2021). The Role of Inflammation in Retinal Neurodegeneration and Degenerative Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010386"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.7861\/clinmed.2022-0046","article-title":"Inflammatory eye disease: An overview of clinical presentation and management","volume":"22","author":"Miller","year":"2022","journal-title":"Clin. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Agarwal, P., Craig, J.P., and Rupenthal, I.D. (2021). Formulation Considerations for the Management of Dry Eye Disease. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020207"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2478\/sjecr-2018-0032","article-title":"Therapeutic Potential of \u201cExosomes Derived Multiple Allogeneic Proteins Paracrine Signaling: Exosomes D-Mapps\u201d is Based on the Effects of Exosomes, Immunosuppressive and Trophic Factors","volume":"20","author":"Harrell","year":"2019","journal-title":"Ser. J. Exp. Clin. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2478\/sjecr-2019-0045","article-title":"Exo-D-Mapps Attenuates Production of Inflammatory Cytokines and Promoted Generation of Immunosuppressive Phenotype in Peripheral Blood Mononuclear Cells","volume":"23","author":"Harrell","year":"2022","journal-title":"Ser. J. Exp. Clin. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2478\/sjecr-2019-0072","article-title":"Therapeutic Potential of \u201cDerived-Multiple Allogeneic Proteins Paracrine Signaling-D-Mapps\u201d in the Treatment of Dry Eye Disease","volume":"23","author":"Harrell","year":"2022","journal-title":"Ser. J. Exp. Clin. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/5584_2018_219","article-title":"Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases","volume":"1089","author":"Harrell","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Harrell, C.R., Djonov, V., and Volarevic, V. (2021). The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052472"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.32604\/biocell.2022.020175","article-title":"Mesenchymal stem cell-derived exosomes as new remedy for the treatment of inflammatory eye diseases","volume":"46","author":"Harrell","year":"2022","journal-title":"BioCell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: The good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000448117","article-title":"Hyperosmolarity and Benzalkonium Chloride Differently Stimulate Inflammatory Markers in Conjunctiva-Derived Epithelial Cells in vitro","volume":"58","author":"Warcoin","year":"2017","journal-title":"Ophthalmic. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.18240\/ijo.2019.09.19","article-title":"Systemic IL-1\u03b2 production as a consequence of corneal HSV-1 infection-contribution to the development of herpes simplex keratitis","volume":"12","author":"Shahnazaryan","year":"2019","journal-title":"Int. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/biof.1587","article-title":"The role of Interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration","volume":"46","author":"Harrell","year":"2020","journal-title":"Biofactors"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Harrell, C.R., Jovicic, N., Djonov, V., and Volarevic, V. (2020). Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12050474"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1016\/j.drudis.2021.06.017","article-title":"Blocking the inflammasome: A novel approach to treat uveitis","volume":"26","author":"Shome","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/bjophthalmol-2020-315911","article-title":"A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation","volume":"105","author":"Wong","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6693542","DOI":"10.1155\/2021\/6693542","article-title":"Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis","volume":"2021","author":"Guo","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/ICL.0000000000000369","article-title":"New Insights Into the Lipid Layer of the Tear Film and Meibomian Glands","volume":"43","author":"Arita","year":"2017","journal-title":"Eye Contact Lens"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.exer.2017.02.008","article-title":"Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD)","volume":"163","author":"Hwang","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.survophthal.2019.08.007","article-title":"Management of meibomian gland dysfunction: A review","volume":"65","author":"Sabeti","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12886-015-0132-x","article-title":"Meibomian gland dysfunction: Hyperkeratinization or atrophy?","volume":"15","author":"Jester","year":"2015","journal-title":"BMC Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/ICO.0000000000001101","article-title":"Automated Measurement of Tear Film Dynamics and Lipid Layer Thickness for Assessment of Non-Sj\u00f6gren Dry Eye Syndrome With Meibomian Gland Dysfunction","volume":"36","author":"Ji","year":"2017","journal-title":"Cornea"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","article-title":"Dysfunctional tear syndrome: Dry eye disease and associated tear film disorders\u2014New strategies for diagnosis and treatment","volume":"27","author":"Milner","year":"2017","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: An immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_33","first-page":"71","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2017.05.007","article-title":"Little Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease","volume":"258","author":"Ratay","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.4049\/jimmunol.182.3.1247","article-title":"Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression","volume":"182","author":"Chauhan","year":"2009","journal-title":"J. Immunol."},{"key":"ref_36","first-page":"4011","article-title":"Rebamipide ophthalmic solution modulates the ratio of T helper cell 17\/regulatory T cells in dry eye disease mice","volume":"19","author":"Fu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Volarevic, V., Zdravkovic, N., Harrell, C.R., Arsenijevic, N., Fellabaum, C., Djonov, V., Lukic, M.L., and Simovic Markovic, B. (2019). Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis. Cells, 8.","DOI":"10.3390\/cells8070709"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/gut.2009.185108","article-title":"Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory\/T effector cell balance and oral tolerance induction","volume":"59","author":"Matteoli","year":"2010","journal-title":"Gut"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/5584_2018_306","article-title":"Molecular Mechanisms Responsible for Anti-inflammatory and Immunosuppressive Effects of Mesenchymal Stem Cell-Derived Factors","volume":"1084","author":"Harrell","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/OPX.0b013e3180485d5f","article-title":"The epidemiology of contact lens related infiltrates","volume":"84","author":"Stapleton","year":"2007","journal-title":"Optom. Vis. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/OPTO.S111130","article-title":"Contact lens wear and dry eyes: Challenges and solutions","volume":"9","author":"Markoulli","year":"2017","journal-title":"Clin. Optom."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1172\/JCI71858","article-title":"Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection","volume":"124","author":"Shi","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s12026-017-8929-8","article-title":"IL-27 regulates the adherence, proliferation, and migration of MSCs and enhances their regulatory effects on Th1 and Th2 subset generations","volume":"65","author":"Xu","year":"2017","journal-title":"Immunol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bjo.2007.124156","article-title":"Idiopathic orbital inflammatory syndrome: Clinical features and treatment outcomes","volume":"91","author":"Swamy","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ajo.2004.06.077","article-title":"Treatment of recalcitrant idiopathic orbital inflamation (chronic orbital myositis) with Infliximab","volume":"138","author":"Garrity","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.trsl.2021.05.005","article-title":"Immune responses to injury and their links to eye disease","volume":"236","author":"Stepp","year":"2021","journal-title":"Transl. Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Greenan, E., Gallagher, S., Khalil, R., Murphy, C.C., and N\u00ed Gabhann-Dromgoole, J. (2021). Advancing Our Understanding of Corneal Herpes Simplex Virus-1 Immune Evasion Mechanisms and Future Therapeutics. Viruses, 13.","DOI":"10.3390\/v13091856"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"17108","DOI":"10.1038\/s41598-017-17400-3","article-title":"Tumor necrosis factor-alpha regulates photoreceptor cell autophagy after retinal detachment","volume":"7","author":"Xie","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ophtha.2012.07.006","article-title":"Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa","volume":"120","author":"Yoshida","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/aos.13899","article-title":"Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract","volume":"97","author":"Fazil","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1002\/jcp.30213","article-title":"Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1","volume":"236","author":"Gu","year":"2021","journal-title":"J. Cell Physiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13528\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:10:38Z","timestamp":1760145038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":51,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232113528"],"URL":"https:\/\/doi.org\/10.3390\/ijms232113528","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]}}}